BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36661242)

  • 1. Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.
    Turner RM; Clements MN; Quartagno M; Cornelius V; Cro S; Ford D; Tweed CD; Walker AS; White IR
    Stat Med; 2023 Apr; 42(8):1127-1138. PubMed ID: 36661242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints.
    Tang N; Yu B
    J Biopharm Stat; 2022 Sep; 32(5):768-788. PubMed ID: 35213275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some practical considerations in three-arm non-inferiority trial design.
    Zhou M; Kundu S
    Pharm Stat; 2016 Nov; 15(6):550-559. PubMed ID: 27681603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.
    Gamalo MA; Tiwari RC; LaVange LM
    Pharm Stat; 2014; 13(1):25-40. PubMed ID: 23913880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
    Li Z; Quartagno M; Böhringer S; van Geloven N
    Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
    Shao Y; Mukhi V; Goldberg JD
    Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
    Ghosh S; Ghosh S; Tiwari RC
    Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial.
    Turner RM; Turkova A; Moore CL; Bamford A; Archary M; Barlow-Mosha LN; Cotton MF; Cressey TR; Kaudha E; Lugemwa A; Lyall H; Mujuru HA; Mulenga V; Musiime V; Rojo P; Tudor-Williams G; Welch SB; Gibb DM; Ford D; White IR;
    BMC Med Res Methodol; 2022 Feb; 22(1):49. PubMed ID: 35184739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian approach to non-inferiority trials for normal means.
    Gamalo MA; Wu R; Tiwari RC
    Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.
    Aupiais C; Alberti C; Schmitz T; Baud O; Ursino M; Zohar S
    BMC Med Res Methodol; 2019 Sep; 19(1):187. PubMed ID: 31533631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample Size Estimation for Non-Inferiority Trials: Frequentist Approach versus Decision Theory Approach.
    Bouman AC; ten Cate-Hoek AJ; Ramaekers BL; Joore MA
    PLoS One; 2015; 10(6):e0130531. PubMed ID: 26076354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some thoughts on sample size: a Bayesian-frequentist hybrid approach.
    Gordon Lan KK; Wittes JT
    Clin Trials; 2012 Oct; 9(5):561-9. PubMed ID: 22865839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.